drug protocol number

I8F-MC-GPIY

drug sponsor

Eli Lilly

drug study

Tirzepatide

drug trial site

Al Moosa Specialized Hospital (al ahsa), King Faisal Specialist Hospital and Research Center (Riyadh), Saudi Airlines Medical Service Center (Jeddah), King Fahad Medical City (Riyadh), Dallah Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah), King Faisal Specialist Hospital and Research Center (Madinah)

drug status

Ongoing

drug phase